Nilotinib improved cognition and motor skills in Parkinson’s trial
WASHINGTON, DC: A treatment for leukaemia, nilotinib (Tasigna, Novartis), improved cognition, motor skills and non-motor…
FEATURED
New drug hope for ‘childhood Alzheimer’s’ after global trials
Charity now set to build new pods for homeless people
Lilly’s Alzheimer’s super drug to be approved ‘any day’
Pensioner with ‘severe dementia’ living in care home is prosecuted
Inquest begins after man took wife’s end-of-life medication
Surveys show public support on euthanasia for mentally ill
INNOVATION
